Neo-adjuvant RFA of NSCLC tumours showed prominent CD8 and CD4 T cell infiltration in the peripheral regions of RFA-treated tumours as well as increased frequency of pro-inflammatory BDCA-3+ DCs in peripheral blood suggesting systemic immune activation (148). The gene discussed is CD8A; the disease is neoplasm.